首页|An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria
An emerging antibacterial nanovaccine for enhanced chemotherapy by selectively eliminating tumor-colonizing bacteria
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
万方数据
Fusobacterium nucleatum(F.nucleatum),an oral anaerobe,is prevalent in colorectal cancer and is closely related to increased cancer cell growth,metastasis,and poor treatment outcomes.Bacterial vaccines cap-able of selectively eliminating bacteria present a promising approach to targeting intratumor F.nuclea-tum,thereby enhancing cancer treatment.Although adjuvants have been employed to enhance the immune response,the vaccine's effectiveness is constrained by inadequate T-cell activation necessary for eradicating intracellular pathogens.In this study,we developed a minimalistic,biomimetic nanovac-cine by integrating highly immunostimulatory adjuvant cholesterol-modified CpG oligonucleotides into the autologously derived F.nucleatum membranes.Compared to the traditional vaccines consisting of inactivated bacteria and Alum adjuvant,the nanovaccine coupled with bacterial membranes and adju-vants could remarkably improve multiple antigens and adjuvant co-delivery to dendritic cells,maximiz-ing their ability to achieve effective antigen presentation and strong downstream immune progress.Notably,the nanovaccine exhibits outstanding selective prophylactic and therapeutic effects,eliminating F.nucleatum without affecting intratumoral and gut microbiota.It significantly enhances chemotherapy efficacy and reduces cancer metastasis in F.nucleatum-infected colorectal cancer.Overall,this work rep-resents the rational application of bacterial nanovaccine and provides a blueprint for future development in enhancing the antitumor effect against bacterial-infected cancer.
Institute of Functional Nano & Soft Materials(FUNSOM),Jiangsu Key Laboratory for Carbon-Based Functional Materials & Devices,Soochow University,Suzhou 215123,China
Department of Gynecologic Oncology,The International Peace Maternity and Child Health Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai 200030,China
Department of Thoracic Surgery,Shanghai Pulmonary Hospital,Tongji University School of Medicine,Shanghai 200433,China
National Research Programs of ChinaNational Research Programs of ChinaNational Natural Science Foundation of ChinaNational Natural Science Foundation of ChinaSuzhou Key Laboratory of Nanotechnology and BiomedicineCollaborative Innovation Centre of Suzhou Nano Science and Technology111 Program from the Ministry of Education of China
NETL
NSTL
万方数据
